Cargando…
StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): study protocol for a randomised controlled clinical trial
BACKGROUND: The standard of care for neovascular age-related macular degeneration (nAMD) involves ongoing intravitreal injections of anti-angiogenic drugs targeting vascular endothelial growth factor (VEGF). The most commonly used anti-VEGF drugs are ranibizumab, bevacizumab and aflibercept. The mai...
Autores principales: | Neffendorf, James E., Desai, Riti, Wang, Yanzhong, Kelly, Joanna, Murphy, Caroline, Reeves, Barnaby C., Chakravarthy, Usha, Wordsworth, Sarah, Lewis, Cornelius, Peacock, Janet, Uddin, Shahir, O’Sullivan, Joe M., Jackson, Timothy L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121938/ https://www.ncbi.nlm.nih.gov/pubmed/27881184 http://dx.doi.org/10.1186/s13063-016-1676-7 |
Ejemplares similares
-
Stereotactic radiotherapy for wet age-related macular degeneration: current perspectives
por: Neffendorf, James E, et al.
Publicado: (2015) -
Prospective In Silico Evaluation of Cone-Beam Computed Tomography-Guided StereoTactic Adaptive Radiation Therapy (CT-STAR) for the Ablative Treatment of Ultracentral Thoracic Disease
por: Schiff, Joshua P., et al.
Publicado: (2023) -
Documentation of adverse events in non-commercial trials of intravitreal injection of anti-VEGF drugs to treat wet age-related macular degeneration (AMD)
por: Reeves, Barnaby C, et al.
Publicado: (2011) -
Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial
por: Dakin, Helen A, et al.
Publicado: (2014) -
Computed tomography-guided vertebroplasty using a stereotactic guidance system (stereo-guide)
por: Epstein, Nancy E.
Publicado: (2010)